The cohort description is described in Tables 1, 2, where the first one shows the characterization of CML patients subjected to RNASeq, indicating age, gender, BCR::ABL1 percentage, and clinical data for blood cells count and creatinine. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.